Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ADAPTIVE BIOTECHNOLOGIES CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2019-08-29 to 2024-08-31
Current total value of award: $385920
Description: CLONOSEQ MINIMAL RESIDUAL DISEASE IN-VITRO DIAGNOSTIC ARRAY FOR THE DEPARTMENT OF PATHOLOGY AT WALTER REED NATIONAL MILITARY MEDICAL CENTER